{"id":2422,"date":"2018-06-01T19:42:00","date_gmt":"2018-06-01T19:42:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=2422"},"modified":"2025-01-15T03:14:09","modified_gmt":"2025-01-15T03:14:09","slug":"nonalcoholic-fatty-liver-disease-burden-saudi-arabia-and-united-arab-emirates-2017-2030","status":"publish","type":"post","link":"https:\/\/cdafound.org\/es\/nonalcoholic-fatty-liver-disease-burden-saudi-arabia-and-united-arab-emirates-2017-2030\/","title":{"rendered":"Carga de la enfermedad por h\u00edgado graso no alcoh\u00f3lico: Arabia Saudita y Emiratos \u00c1rabes Unidos, 2017-2030"},"content":{"rendered":"<h2 class=\"wp-block-heading\">Resumen<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Antecedentes \/ Objetivo<\/h3>\n\n\n\n<p>Debido a los niveles epid\u00e9micos de obesidad y diabetes mellitus (DM) tipo 2, la enfermedad del h\u00edgado graso no alcoh\u00f3lico (NAFLD) y la esteatohepatitis no alcoh\u00f3lica (NASH) resultante ser\u00e1n factores determinantes de la enfermedad hep\u00e1tica<br>carga en los pr\u00f3ximos a\u00f1os en Arabia Saudita y Emiratos \u00c1rabes Unidos (EAU).<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><br>Materiales y m\u00e9todos<\/h3>\n\n\n\n<p>Se utilizaron modelos para estimar la progresi\u00f3n de la enfermedad de NAFLD y NASH, principalmente sobre la base de los cambios en las tasas de prevalencia de obesidad y DM en adultos. Las estimaciones publicadas y las entrevistas a expertos se utilizaron para construir y validar las proyecciones del modelo.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><br>Resultados<\/h3>\n\n\n\n<p>En ambos pa\u00edses, la prevalencia de NAFLD aument\u00f3 hasta 2030 en paralelo a los aumentos proyectados en la prevalencia de obesidad y DM. Para 2030, se estimaba que hab\u00eda 12,534,000 casos de NAFLD en Arabia Saudita y 372,000 casos en los Emiratos \u00c1rabes Unidos. Los aumentos en los casos de NASH fueron relativamente mayores que los casos de NAFLD debido al envejecimiento de la poblaci\u00f3n y la progresi\u00f3n de la enfermedad. Asimismo, se prev\u00e9 que los casos prevalentes de cirrosis compensada y enfermedad hep\u00e1tica avanzada se dupliquen al menos para 2030, mientras que las muertes hep\u00e1ticas incidentes anuales aumentan en ambos pa\u00edses a 4800 muertes en Arabia Saudita y 140 muertes en los Emiratos \u00c1rabes Unidos.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><br>Conclusiones<\/h3>\n\n\n\n<p>Las altas tasas continuas de obesidad y DM en adultos, en combinaci\u00f3n con el envejecimiento de la poblaci\u00f3n, sugieren que la enfermedad hep\u00e1tica avanzada y la mortalidad atribuible a NAFLD \/ NASH aumentar\u00e1n en ambos pa\u00edses. Ser\u00e1 necesario reducir el crecimiento de la poblaci\u00f3n de NAFLD, junto con posibles opciones terap\u00e9uticas, para reducir la carga de enfermedad hep\u00e1tica.<\/p>\n\n\n\n<p><strong>Pa\u00edses:<\/strong> Arabia Saudita, Emiratos \u00c1rabes Unidos<\/p>\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link has-text-color wp-element-button\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29956688\/\" target=\"_blank\" rel=\"noreferrer noopener\">Lea el informe completo<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Summary Background\/Aim Due to epidemic levels of obesity and type 2 diabetes mellitus (DM), nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH) will be driving factors in liver diseaseburden in the coming years in Saudi Arabia and United Arab Emirates (UAE). Materials and Methods Models were used to estimate NAFLD and NASH disease [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":3468,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[24],"publication-author":[655,844,841,843,846,842,652,839,840,845,535,838,494,648],"class_list":["post-2422","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-nafld","publication-author-abaalkhail-f","publication-author-al-hamoudi-wk","publication-author-al-khathlan-a","publication-author-al-quraishi-h","publication-author-al-rifai-a","publication-author-al-zaabi-m","publication-author-alghamdi-m","publication-author-aljumah-aa","publication-author-alswat-k","publication-author-babatin-ma","publication-author-estes-c","publication-author-hashim-a","publication-author-razavi-h","publication-author-sanai-fm"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts\/2422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/comments?post=2422"}],"version-history":[{"count":11,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts\/2422\/revisions"}],"predecessor-version":[{"id":7538,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/posts\/2422\/revisions\/7538"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/media\/3468"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/media?parent=2422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/categories?post=2422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/tags?post=2422"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/publication-author?post=2422"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}